Lunai Bioworks

YTD

ALL

Why Robinhood?

You can watch Lunai Bioworks and buy or sell other stocks, ETFs, and their options commission-free!

About RENB

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21.

CEO

David Weinstein

CEODavid Weinstein

Employees

Employees29

Headquarters

Los Angeles, California

HeadquartersLos Angeles, California

Founded

2011

Founded2011

Employees

Employees29

RENB Key Statistics

Market cap

25.19M

Market cap25.19M

Price-Earnings ratio

-0.13

Price-Earnings ratio-0.13

Dividend yield

—

Dividend yield—

Average volume

162.01K

Average volume162.01K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$21.00

52 Week high$21.00

52 Week low

$1.13

52 Week low$1.13

People also own

Based on the portfolios of people who own RENB. This list is generated using Robinhood data, and it’s not a recommendation.